The impact of the time interval on in-vitro fertilisation success after failure of the first attempt

References

• Akman MA, Erden HF, Tosun SB, Bayazit N, Aksoy E, Bahceci M. 2001. Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial. Human Reproduction 16:868–870.
   PubMed Web of Science ®Google Scholar
• Al-Inany HG, Youssef MA, Aboulghar M, Broekmans F, Sterrenburg M, Smit J et al. 2011. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Systemic Review(11):CD001750.
   Google Scholar
• Berkkanoglu M, Isikoglu M, Arici F, Ozgur K. 2008. What is the best time to perform intracytoplasmic sperm injection/embryo transfer cycle after hysteroscopic surgery for an incomplete uterine septum? Fertility and Sterility 90:2112–2115.
   PubMedGoogle Scholar
• Bhattacharya S, Maheshwari A, Mollison J. 2013. Factors associated with failed treatment: an analysis of 121,744 women embarking on their first IVF cycles. PLoS One 8:e82249.
   PubMed Web of Science ®Google Scholar
• Bosch E, Ezcurra D. 2011. Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients. Reproductive Biology and Endocrinology 9:82.
   PubMed Web of Science ®Google Scholar
• Bosch E, Labarta E, Crespo J, Simón C, Remohí J, Jenkins J et al. 2010. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilisation-analysis of over 4000 cycles. Human Reproduction 25:2092–2100.
   PubMed Web of Science ®Google Scholar
• Devroey P, Aboulghar M, Garcia-Velasco J, Griesinger G, Humaidan P, Kolibianakis E et al. 2009. Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment. Human Reproduction 24:764–774.
   PubMed Web of Science ®Google Scholar
• Doldi N, Persico P, De Santis L, Rabelotti E, Papaleo E, Ferrari A. 2005. Consecutive cycles in in vitro fertilisation–embryo transfer. Gynecological Endocrinology 20:132–136.
   PubMed Web of Science ®Google Scholar
• Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. 2000. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertility and Sterility 73:1155–1158.
   PubMed Web of Science ®Google Scholar
• Huang JY, Rosenwaks Z. 2012. In vitro fertilisation treatment and factors affecting success. Best Practice and Research Clinical Obstetrics and Gynaecology 26:777–788.
   PubMedGoogle Scholar
• Karayalcın R, Ozyer S, Ozcan S, Uzunlar O, Gürlek B, Moraloğlu O et al. 2012. Office hysteroscopy improves pregnancy rates following IVF. Reproductive Biomedicine Online 25:261–266.
   PubMed Web of Science ®Google Scholar
• Kolibianakis E, Bourgain C, Albano C, Osmanagaoglu K, Smitz J, Van Steirteghem A et al. 2002. Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertility and Sterility 78:1025–1029.
   PubMed Web of Science ®Google Scholar
• Li R, Hao G. 2009. Local injury to the endometrium: its effect on implantation. Current Opinion in Obstetrics and Gynecology 2:236–239.
   Google Scholar
• Moraloglu Ö, Kilic S, Karayalçin R, Yuksel B, Tasdemir N, Işik A et al. 2008. Comparison of GnRH agonists and antagonists in normoresponder IVF/ICSI in Turkish female patients. Advanced Therapies 25:266–273.
   PubMed Web of Science ®Google Scholar
• Nadro LG, Fleming R, Howles CM, Bosch E, Hamamah S, Ubaldi FM et al. 2011. Conventional ovarian stimulation no longer exists: welcome to the age of individualized ovarian stimulation. Reproductive BioMedicine Online 23:141–148.
   PubMedGoogle Scholar
• Orvieto R, Patrizio P. 2013. GnRH agonist versus GnRH antagonist in ovarian stimulation: an ongoing debate. Reproductive BioMedicine Online 26:4–8.
   PubMed Web of Science ®Google Scholar
• Rackow BW, Kliman HJ, Taylor HS. 2008. GnRH antagonists may affect endometrial receptivity. Fertility and Sterility 89:134–139.
   Google Scholar
• Racowsky C, Combelles CM, Nureddin A, Pan Y, Finn A, Miles L et al. 2003. Day 3 and day 5 morphological predictors of embryo viability. Reproductive Biomedicine Online 6:323–331.
   PubMedGoogle Scholar
• Ragni G, Mosconi P, Baldini MP, Somigliana E, Vegetti W, Caliari I et al. 2005. Health-related quality of life and need for IVF in 1000 Italian infertile couples. Human Reproduction 20:1286–1291.
   PubMed Web of Science ®Google Scholar
• Raziel A, Schachter M, Strassburger D, Bern O, Ron-El R, Friedler S. 2007. Favorable influence of local injury to the endometrium in intracytoplasmic sperm injection patients with high-order implantation failure. Fertility and Sterility 87:198–201.
   PubMed Web of Science ®Google Scholar
• Reichman, DE, Chung P, Meyer L, Greenwood E, Davis O, Rosenwaks Z et al. 2013. Consecutive gonadotropin-releasing hormone-antagonist in vitro fertilisation cycles: does the elapsed time interval between successive treatments affect outcomes? Fertility and Sterility 99:1277–1282.
   PubMed Web of Science ®Google Scholar
• Schachter M, Friedler S, Ron-El R, Zimmerman AL, Strassburger D, Bern O et al. 2008. Can pregnancy rate be improved in gonadotropin releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study. Fertility and Sterility 90:1087–1093.
   PubMed Web of Science ®Google Scholar
• Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C, Thomas S. 2011. Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilisation: a prospective randomized trial comparing fresh and frozen-thawed embryo transfers in high responders. Fertility and Sterility 96:516–518.
   PubMed Web of Science ®Google Scholar
• Steptoe PC, Edwards RG. 1978. Birth after the reimplantation of a human embryo. Lancet 12:366.
   Google Scholar
• Tesarik J, Hazout A, Menoza-Tesarik R, Mendoza N, Mendoza C. 2006. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles. Human Reproduction 21:2572–2579.
   PubMed Web of Science ®Google Scholar